PCV70 COST-EFFECTIVENESS OF ROSUVASTATIN 20 MG IN SECONDARYPREVENTION PATIENTS IN THE UNITED STATES
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72789-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)72789-3/fulltext
Section Title :
Section Order :
352
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72789-3&doi=10.1016/S1098-3015(10)72789-3